EMA
approval
· 2026-08-27
EMA Authorised: Tecvayli
Summary
Tecvayli has been authorised by the EMA for multiple myeloma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Status: Authorised. Therapeutic area: Multiple Myeloma. Decision date: 20/08/2026